Cdc37 as a co-chaperone to Hsp90

Area of Science:

• Molecular biology
• Cellular signaling
• Cancer biology

Background:

• The co-chaperone p50/Cdc37 is crucial for Hsp90 chaperone activity, particularly in regulating protein kinases.
• The Hsp90/Cdc37 complex governs protein kinase folding, impacting numerous intracellular signaling networks and cellular processes.

Purpose of the Study:

• To explore the multifaceted roles of Cdc37 in cellular regulation, carcinogenesis, and aging.
• To evaluate Cdc37 as a potential therapeutic target in cancer and a factor in longevity.

Main Methods:

• Literature review and analysis of Cdc37's involvement in protein kinase regulation.
• Examination of Cdc37's expression patterns in cancer and its link to signaling pathways.
• Investigation of Cdc37's connection to protein aggregation, autophagy, and aging.

Main Results:

• Cdc37's regulation of protein kinases places it at the center of cell growth pathways, making it a key player in carcinogenesis.
• Elevated Cdc37 expression in some cancers offers potential for selective targeting, while its control over multiple pathways suggests robustness against resistance.
• Cdc37's links to protein folding, autophagy, and age-related chaperone decline indicate a role in longevity and aging processes.

Conclusions:

• Cdc37 is a significant co-chaperone with implications for cancer therapy and understanding aging.
• Further research into Cdc37's maintenance and decline in aging organisms is warranted to elucidate its role in longevity.